Tinea Unguium Tài liệu tham khảo

Cập nhật: 23 April 2026
Được đánh giá bởi
  1. Hainer BL. Dermatophyte infections. Am Fam Physician. 2003 Jan;67(1):101-108. PMID: 12537173
  2. Vander-Straten MR, Hossain MA, Ghannoum MA. Cutaneous infections: dermatophytosis, onychomycosis and tinea versicolor. Infect Dis Clin N Am. 2003 Mar;17(1):87-112. PMID: 12751262
  3. Baran R. Feuilhade M, Combernale P, et al. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. Br J Dermatol. 2000 Jun;142(6):1177-1183. PMID: 10848743
  4. Baran R. Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. Br J Dermatol. 2001 Oct;145(Suppl 60):15-19. PMID: 11777260
  5. Gray JA. Onychomycosis: new treatments are effective. Clinician Rev. 2002;12(9):7-88
  6. Crawford F, Young P, Godfrey C, et al. Oral treatments for toenail onychomycosis. Arch dermatol. 2002 Jun;138(6):811-816. PMID: 12056964
  7. Haria M, Bryson HM. Amorolfine: a review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections. Drugs. 1995 Jan;49(1):103-120. PMID: 7705210
  8. Lecha M. Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomized trial in Spain. Br J Dermatol. 2001 Oct;145(Suppl 60):21-26. PMID: 11777261
  9. Mahoney JM, Bennet J, Olsen B. The diagnosis of onychomycosis. Dermatol Clin. 2003 Jul;21(3):463-467. PMID: 12956198
  10. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol. 2003 Mar;148(3):402-410. PMID: 12653730
  11. Rodgers P, Bassler M. Treating onychomycosis. Am Fam Physician. 2001 Feb;63(4):663-678. PMID: 11237081
  12. Rehmus WE. Onychomycosis. Merck Manual; 2012 Feb. http://www.merckmanuals.com/professional/dermatologic_disorders/nail_disorders/onychomycosis.html. Accessed 23 Aug 2013
  13. Gilbert DN, Moellering RC, Eliopoulos GM, et al. The Sanford Guide to Antimicrobial Therapy. 37th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2007.
  14. Habif TP. Superficial fungal infections. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Pennsylvania (PA): Mosby, Elsevier; 2004:409-439.
  15. MedWorm http://www.medworm.com/rss/index.php/Dermatology/12/ http://www.medworm.com/rss/medicalfeeds/specialities/Dermatology-News.xml
  16. MedWorm http://www.medworm.com/rss/index.php/Pediatrics/33/ http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics-News.xml
  17. Blumberg M, Kantor G. Onychomycosis. eMedicine. http://www.emedicine.com/derm/topic300.htm.Crawford
  18. Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. British Association of Dermatologists' guidelines for the management of onychomycosis 2014. Br J Dermatol. 2014 Nov;171(5):937-958. doi: 10.1111/bjd.13358. PMID: 25409999
  19. Bortolussi R, Martin S; Canadian Pediatric Society, Infectious Diseases and Immunization Committee. Antifungal agents for the common outpatient pediatric infections. Canadian Pediatric Society. https://www.cps.ca/. Feb 2018.
  20. Goldstein AO, Bhatia N. Onychomycosis: management. UpToDate. https://www.uptodate.com/. 22 Dec 2025. Accessed 19 Sep 2024.
  21. Goldstein AO, Bhatia N. Onychomycosis: epidemiology, clinical features, and diagnosis. UpToDate. https://www.uptodate.com/. 07 Jan 2026. Accessed 19 Sep 2024.
  22. Westerberg DP, Voyack MJ. Onychomycosis: Current trends in diagnosis and treatment. Am Fam Physician. 2013 Dec;88(11):762-770. PMID: 24364524
  23. Bodman MA, Syed HA, Krishnamurthy K. Onychomycosis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan.
  24. Nenoff P, Reinel D, Mayser P, et al. S1 Guideline onychomycosis. J Dtsch Dermatol Ges. 2023 Jun;21(6):678-692. doi: 10.1111/ddg.14988. PMID: 37212291